300110 Huaren Pharmaceutical
- 3.78
- +0.06+1.61%
Huaren Pharmaceutical News
Express News | Huaren Pharmaceutical: The subsidiary obtained a medical device registration certificate using a disposable peripheral blood collector
Express News | The State Organization Drug Joint Procurement Office reported on interviews with bidding companies for some varieties of drugs collected by the State Organization with abnormal prices
Huaren Pharmaceutical (300110.SZ): Bai Peng and Meng Xiangyuan were appointed as vice presidents
Huaren Pharmaceutical (300110.SZ) issued an announcement. The company will hold the 8th board meeting on April 23, 2024...
Huaren Pharmaceutical (300110.SZ) announced its 2023 annual results, with net profit of 188 million yuan, an increase of 4.03% over the previous year
Huaren Pharmaceutical (300110.SZ) announced its 2023 annual results, with operating revenue of 1,636 billion yuan, a year-on-year increase...
Express News | Huaren Pharmaceutical: Subsidiary obtains medical device registration certificate
Huaren Pharma's Unit Gets Nod for Medical Device
Huaren Pharmaceutical's (SHE:300110) unit, Qingdao Huaren Medical, received approval for its disposable infusion connector disinfection cap from the food and drug administrator of China's Shandong Pro
Express News | Huaren Pharmaceutical: The subsidiary obtained a medical device registration certificate for disposable infusion joints, disinfectant caps
Huaren Pharmaceutical (300110.SZ): The beverage business includes products such as electrolyte supplements, pure water, large buckets of water, glucose rehydration solutions, solid drinks, etc. developed and produced by the company
Gelonghui March 18 | Huaren Pharmaceutical (300110.SZ) said on the investor interactive platform that the company is actively laying out major health product lines such as beverages. The beverage business includes products such as electrolyte refills, purified water, large buckets of water, glucose rehydration solutions, and solid beverages developed and produced by the company itself. Among them, Jiuyuanjiu Electrolyte Replenishment Solution is used to supplement the body's water loss and maintain the body's acid-base balance and electrolyte balance.
Huaren Pharmaceutical (300110.SZ): Mainly engaged in R&D, production and sales of peritoneal dialysis solutions, large infusions, medical devices, etc.
Gelonghui, March 15 | Huaren Pharmaceutical (300110.SZ) said on the investor interactive platform that the company is mainly engaged in R&D, production and sales of peritoneal dialysis solutions, large infusions (including non-PVC soft bags, upright soft bags, plastic bottles, large glass bottles), respiratory medicine, drugs in the field of refining, and raw materials, supporting pharmaceutical packaging materials, medical devices, etc. The X virus proposed by WHO does not represent a specific virus; it refers to a known or unknown virus that may infect humans on a large scale and cause public health events.
Huaren Pharmaceutical (300110.SZ): The company and its wholly-owned subsidiaries have been re-certified as high-tech enterprises
Gelonghui, Feb. 28 | Huaren Pharmaceutical (300110.SZ) announced that the company and its wholly-owned subsidiary Qingdao Huaren Medical Products Co., Ltd. have each received high-tech enterprise certificates jointly issued by the Qingdao Municipal Bureau of Science and Technology, the Qingdao Municipal Finance Bureau, and the Qingdao Municipal Taxation Bureau of the State Administration of Taxation, and they have all been re-certified as high-tech enterprises.
Huaren Pharma's Unit Gets Nod to Add Specifications to Antibiotic Product
China's National Medical Products Administration approved the supplementary application of Huaren Pharmaceutical's (SHE:300110) unit, Anhui Hengxing Pharmaceutical, to add new specifications to its le
Huaren Pharmaceutical (300110.SZ): Wholly-owned subsidiary levofloxacin injection supplement specifications obtained drug registration certificate
Gelonghui, Feb. 21丨Huaren Pharmaceutical (300110.SZ) announced that recently, Anhui Hengxing Pharmaceutical Co., Ltd. (“Anhui Hengxing Pharmaceutical”), a wholly-owned subsidiary of Huaren Pharmaceutical Co., Ltd., received the “Drug Supplement Application Approval Notice” for the “Levofloxacin Injection 10ml: 0.25g Specification” approved and issued by the State Drug Administration. Levofloxacin injection is suitable for hospital-acquired pneumonia, community-acquired pneumonia, acute bacterial sinusitis, acute bacterial attacks of chronic bronchitis, complex skin and skin structural infections, uncomplicated skin and soft tissue infections, slow
Huaren Pharmaceutical (300110.SZ): Huaren Tongji obtained cosmetics production license
Gelonghui, Feb. 8: Huaren Pharmaceutical (300110.SZ) announced that recently, Hubei Huaren Tongji Pharmaceutical Co., Ltd. (hereinafter referred to as “Huaren Tongji”), a holding subsidiary of Huaren Pharmaceutical Co., Ltd., received a “Cosmetics Production License” issued by the Hubei Drug Administration. The cosmetics business is one of the business segments of Huaren Tongji, a holding subsidiary of the company. The company name Jitang Cosmetics was developed by the “Huaren Tongji Joint Laboratory” in collaboration with Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology. It focuses on medical scientific skin care. Currently, the main products include collagen sleeping masks and small molecule collagen eggs
Huaren Pharmaceutical (300110.SZ): Anhui Hengxing Pharmaceutical has been re-certified as a high-tech enterprise
Gelonghui, Feb. 8, 丨 Huaren Pharmaceutical (300110.SZ) announced that recently, Anhui Hengxing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huaren Pharmaceutical Co., Ltd., received a high-tech enterprise certificate jointly issued by the Anhui Provincial Department of Science and Technology, the Anhui Provincial Department of Finance, and the Anhui Provincial Taxation Bureau of the State Administration of Taxation, and the wholly-owned subsidiary Huaren Pharmaceutical (Rizhao) Co., Ltd. received a high-tech enterprise certificate jointly issued by the Shandong Provincial Department of Science and Technology, the Shandong Provincial Department of Finance, and the State Administration of Taxation.
Express News | Leading the way and implementing rapid implementation, A-share companies continue to increase their holdings and repurchases continue to be popular
Huaren Pharmaceutical (300110.SZ): Chairman Yang Xiaodong increased his holdings by 10,000 shares
Gelonghui, Feb. 6, 丨 Huaren Pharmaceutical (300110.SZ) announced that on February 6, 2024, the company received a notice from Mr. Yang Xiaodong, the chairman of the company. Based on his confidence in the company's future development prospects and recognition of the long-term investment value of the company's shares, Mr. Yang Xiaodong used his own funds to increase his shareholding by 10,000 shares through the Shenzhen Stock Exchange stock trading system on February 6, 2024.
Huaren Pharmaceutical (300110.SZ): Chairman Yang Xiaodong increased his holdings by 140,000 shares
Gelonghui, Feb. 5, 丨 Huaren Pharmaceutical (300110.SZ) announced that on February 5, 2024, the company received a notice from Mr. Yang Xiaodong, the chairman of the company. Based on his confidence in the company's future development prospects and recognition of the long-term investment value of the company's shares, Mr. Yang Xiaodong used his own funds to increase his shareholding by 140,000 shares through the Shenzhen Stock Exchange stock trading system on February 5, 2024.
Huaren Pharmaceutical (300110.SZ): Received a medical device registration certificate for “disposable negative pressure drainage”
Gelonghui, January 18, 丨 Huaren Pharmaceutical (300110.SZ) announced that recently, Qingdao Huaren Medical Products Co., Ltd., a wholly-owned subsidiary of Huaren Pharmaceutical Co., Ltd., received a “Medical Device Registration Certificate” for a “disposable negative pressure drainage device” approved and issued by the Shandong Drug Administration.
Huaren Pharmaceutical (300110.SZ): The company actively lays out a large health product line
Gelonghui, January 17丨Huaren Pharmaceutical (300110.SZ) said on the investor interactive platform that the company is actively developing a large health product line. In terms of cosmetics business, Mingjitang Cosmetics was developed by the subsidiary Huaren Tongji Joint Laboratory in collaboration with Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, focusing on medical scientific skin care. Currently, the main products are collagen sleeping mask, small molecule collagen water, vitamin E moisturizing cream, vitamin E lotion, etc. Renzhijingyan series of cosmetics were developed by the company's subsidiary Huaren Medical Products Co., Ltd., and the current products are
Huaren Pharmaceutical (300110.SZ): The company currently has no products or orders related to COVID-19 testing
Gelonghui, January 5 | Huaren Pharmaceutical (300110.SZ) said on the investor interactive platform that the company is mainly engaged in R&D, production and sales of peritoneal dialysis solutions, respiratory medicine, large infusions (including non-PVC soft bags, plastic bottles, large glass bottles), drugs used in the field of refining and raw materials, supporting pharmaceutical packaging materials, and medical devices. The company currently has no products or orders related to COVID-19 testing.
Analysis
Price Target
No Data
